Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1997-10-1
|
pubmed:abstractText |
In seronegative autologous bone marrow transplanted (ABMT) patients, a sustained cell-mediated immunity (CMI) has been shown to impair the antibody response after measles vaccination. To investigate if this might be caused by a preferential Th1 cytokine response, interferon (IFN)-gamma and interleukin (IL)-10 production of peripheral blood mononuclear cells (PBMC) was analyzed after measles antigen (M-ag) stimulation in vitro. The non-specific immune response was measured by IFN-alpha, and IL-12 analyses. Fifty non-vaccinated patients following ABMT or allogeneic bone marrow transplantation (BMT) were included. IFN-gamma production was significantly higher in patients with a retained CMI to measles than in patients without (2.3 vs 0.8 IU/ml; P = 0.01). Only a non-significant tendency was seen in IL-10 production (48.6 vs 26.7 pg/ml; NS), whereas no difference was found in IFN-alpha or IL-12 production. A positive correlation between IFN-gamma and IL-10 production was found (r(s) = 0.49; P < 0.001). After vaccination of 14 ABMT children, there was an increase in PBMC IFN-gamma production in vitro (2.5 vs <0.1 IU/ml; P < 0.05), whereas no changes were seen in the IL-10, IFN-alpha, or antibody levels. These results suggest that both Th1 and Th2 cytokine production are increased by M-ag stimulation in patients with a retained CMI to measles, but the Th1 response seems to be stronger. The preferential Th1 stimulation and increase in IFN-gamma production after vaccination may lead to a reduction in the humoral immune response which may explain the negative correlation between antibody production and T cell reactivity prior to vaccination.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0268-3369
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
317-23
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9285547-Adolescent,
pubmed-meshheading:9285547-Adult,
pubmed-meshheading:9285547-Antigens, Viral,
pubmed-meshheading:9285547-Bone Marrow Transplantation,
pubmed-meshheading:9285547-Child,
pubmed-meshheading:9285547-Child, Preschool,
pubmed-meshheading:9285547-Cytokines,
pubmed-meshheading:9285547-Humans,
pubmed-meshheading:9285547-Immunity, Cellular,
pubmed-meshheading:9285547-Infant,
pubmed-meshheading:9285547-Measles Vaccine,
pubmed-meshheading:9285547-Measles virus,
pubmed-meshheading:9285547-Middle Aged,
pubmed-meshheading:9285547-Receptors, Interleukin-2,
pubmed-meshheading:9285547-Th1 Cells,
pubmed-meshheading:9285547-Th2 Cells,
pubmed-meshheading:9285547-Vaccination
|
pubmed:year |
1997
|
pubmed:articleTitle |
Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination.
|
pubmed:affiliation |
Department of Infectious Diseases, Uppsala University Hospital, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|